Franklin Street Advisors Inc Abb Vie Inc. Transaction History

Franklin Street Advisors Inc

$1.48 Billion
Q3 2024

A detailed history of Franklin Street Advisors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Franklin Street Advisors Inc holds 173,656 shares of ABBV stock, worth $29.8 Million. This represents 2.31% of its overall portfolio holdings.

Number of Shares

173,656

Previous 179,712 3.37%

Holding current value

$29.8 Million

Previous $30.8 Million 11.26%

% of portfolio

2.31%

Previous 2.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$163.84 - $199.33 $992,215 - $1.21 Million	-6,056 Reduced 3.37%	173,656 $34.3 Million
Q2 2024 Jul 18, 2024	SELL	$154.79 - $180.76 $1.41 Million - $1.64 Million	-9,083 Reduced 4.81%	179,712 $30.8 Million
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $474,505 - $540,654	-2,969 Reduced 1.55%	188,795 $34.4 Million
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $1.69 Million - $1.9 Million	-12,268 Reduced 6.01%	191,764 $29.7 Million
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $1.53 Million - $1.78 Million	11,478 Added 5.96%	204,032 $30.4 Million
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $250,311 - $311,496	-1,889 Reduced 0.97%	192,554 $25.9 Million
Q1 2023 Apr 12, 2023	SELL	$144.61 - $166.54 $5.14 Million - $5.92 Million	-35,520 Reduced 15.45%	194,443 $31 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $1.78 Million - $2.14 Million	12,880 Added 5.93%	229,963 $37.2 Million
Q3 2022 Oct 11, 2022	SELL	$134.21 - $153.93 $5.01 Million - $5.75 Million	-37,342 Reduced 14.68%	217,083 $29.1 Million
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $2.92 Million - $3.71 Million	-21,213 Reduced 7.7%	254,425 $39 Million
Q1 2022 Apr 18, 2022	SELL	$131.98 - $163.75 $7.7 Million - $9.56 Million	-58,353 Reduced 17.47%	275,638 $44.7 Million
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $5.25 Million - $6.64 Million	48,826 Added 17.12%	333,991 $45.2 Million
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $65,648 - $74,521	617 Added 0.22%	285,165 $30.8 Million
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $1.07 Million - $1.19 Million	-10,134 Reduced 3.44%	284,548 $32.1 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $548,839 - $604,206	5,365 Added 1.85%	294,682 $31.9 Million
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $328,962 - $444,134	4,087 Added 1.43%	289,317 $31 Million
Q3 2020 Oct 21, 2020	BUY	$85.91 - $100.83 $534,703 - $627,565	6,224 Added 2.23%	285,230 $25 Million
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $525,329 - $702,968	-7,160 Reduced 2.5%	279,006 $27.4 Million
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $6.87 Million - $10.4 Million	106,456 Added 59.24%	286,166 $21.8 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $4.32 Million - $5.4 Million	59,830 Added 49.91%	179,710 $15.9 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $888,836 - $1.07 Million	-14,113 Reduced 10.53%	119,880 $9.08 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $2.41 Million - $3.08 Million	-36,696 Reduced 21.5%	133,993 $9.74 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $353,995 - $416,635	-4,589 Reduced 2.62%	170,689 $13.8 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $46,320 - $57,125	595 Added 0.34%	175,278 $16.2 Million
Q3 2018 Oct 05, 2018	SELL	$88.91 - $98.84 $485,359 - $539,567	-5,459 Reduced 3.03%	174,683 $16.5 Million
Q2 2018 Jul 16, 2018	BUY	$89.78 - $106.23 $51,892 - $61,400	578 Added 0.32%	180,142 $16.7 Million
Q1 2018 Apr 11, 2018	BUY	$92.01 - $123.21 $146,203 - $195,780	1,589 Added 0.89%	179,564 $17 Million
Q4 2017 Jan 10, 2018	SELL	$89.56 - $98.21 $565,123 - $619,705	-6,310 Reduced 3.42%	177,975 $17.2 Million
Q3 2017 Oct 11, 2017	BUY	$69.85 - $89.22 $12.9 Million - $16.4 Million	184,285	184,285 $16.4 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.

Account

Franklin Street Advisors Inc Abb Vie Inc. Transaction History